https://www.avient.com/sites/default/files/resources/PolyOne%2520Investor%2520Presentation%2520Jefferies%25202013%2520Global%2520Industrial%2520Conference_Posting.pdf
Use of Non GAAP Measures Page 3 -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% PolyOne S&P 500 Strategy and Execution Drive Results Page 4 All time closing high of $29.48 2013年8月1日 • 15 consecutive quarters of double digit EPS growth • 42% CAGR adjusted EPS expansion 2006-2012 • YTD stock price has increased 42% versus 20% growth in the S&P 400% increase in market cap, from $0.7b to $2.8b since 2006 The World’s Premier Provider of Specialized Polymer Materials, Services & Solutions Four Pillar Strategy Page 5 PP&S 15% Specialty 60% Distribution 25% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010* 2011* 2012* 2015 Target A dj us te d Ea rn in gs P er S ha re Appliance 6% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 4% Consumer 9% Packaging 18% Industrial 10% Misc. 5% HealthCare 9% Transportation 16% Textiles 1% United States 70% Europe 14% Canada 8% Asia 5% Latin America 3% 2012 Revenues: $4.0 Billion* End Markets* 2012 Revenues: $4.0 Billion* EPS Page 6 * Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms & excludes discontinued operations PolyOne At A Glance * Restated to exclude discontinued operations Old PolyOne Transformation *Operating Income excludes corporate charges and special items **Pro Forma results include Spartech and Glasforms acquisitions, Specialty Coatings reclass and excludes discontinued operations 2% 34% 43% 45% 60% 62% 65- 75% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2012 2012 PF** H1'13 2015 % o f O pe ra ti ng In co m e* JV's PP&S Distribution Specialty Specialty OI $5M $46M $87M $114M $150M $98M Target Mix Shift Highlights Specialty Transformation 2015 Target Page 7 2006 H1 2013 2015 Where we were Where we are Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 12.6% 12 – 16% Global Specialty Engineered Materials 1.1% 9.2% 12 – 16% Designed Structures & Solutions -- 4.4% 8 – 10% Performance Products & Solutions 5.4% 8.3% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 62% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.4% 15% 4) Adjusted EPS Growth N/A 26% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 8 *Percentage of Specialty Platform revenue from products introduced in last five years 11.5% 46.5% 2006 Q2 2013 $20.3 $44.7 2006 TTM Q2'13 14.3% 31.1% 2006 Q2 2013 Research & Development Spending Specialty Platform Vitality Index Progression* Innovation Drives Earnings Growth ($ millions) Specialty Platform Gross Margin % Page 9 We are Experts in Polymer Science and Formulation Polymer Science Formulation Chemistry Processing Inputs Base Resins Additives Modifiers Colorants Specialized Polymer Materials, Services, and Solutions Expertise Satisfied Consumers PolyOne Customer Innovative Products & Services Marketplace Demands Performance Requirements Value Drivers Page 10 Positioned for Strong Growth 2015 Target Rev: $5B Adj. Net debt $ 638.8 Adjusted EBITDA Q3 2012 Q4 2012 Q1 2013 Q2 2013 Total PolyOne Income before income taxes $ 30.6 $ (1.1) $ 15.7 $ 62.9 $ 108.1 PolyOne Interest expense, net 12.4 13.7 15.6 16.6 58.3 PolyOne Depreciation and amortization 17.0 15.5 19.0 25.8 77.3 PolyOne Special items in EBITDA 8.3 26.5 27.7 (5.2) 57.3 PolyOne Adjusted EBITDA 68.3 54.6 78.0 100.1 301.0 Pro forma Spartech EBITDA 16.8 14.7 11.2 - 42.7 Pro forma EBITDA $ 85.1 $ 69.3 $ 89.2 $ 100.1 $ 343.7 PolyOne Investor Presentation�Jefferies 2013 Global Industrials Conference��2013年8月13日� Forward – Looking Statements Use of Non GAAP Measures Strategy and Execution Drive Results Four Pillar Strategy PolyOne�At A Glance Mix Shift Highlights Specialty Transformation Proof of Performance & 2015 Goals Innovation Drives Earnings Growth We are Experts in Polymer Science and Formulation Positioned for Strong Growth First Half 2013 Financial Highlights Debt Maturities & Liquidity Summary – 6/30/13 Use of Cash Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/Credit%2520Suisse%2520June%252026%25202013.pdf
Use of Non GAAP Measures Page 3 -150.00% -100.00% -50.00% 0.00% 50.00% 100.00% 150.00% 200.00% 250.00% 300.00% 350.00% PolyOne S&P 500 Strategy and Execution Drive Results – Since 2006: Page 4 All time closing high of $26.63 2013年5月28日 • 14 consecutive quarters of double digit EPS growth • 380 basis point increase in return on sales • 300% share price expansion • 300% increase in total shareholder return • 42% CAGR EPS expansion • $1.8 billion increase in market cap • Track record of successful acquisitions The World’s Premier Provider of Specialized Polymer Materials, Services & Solutions Four Pillar Strategy Page 5 2013 Portfolio Transformation Highlights • Substantial organic mix improvement drives 29% increase in first quarter EPS – 14th consecutive quarter of double-digit EPS growth • Completed acquisition of Spartech • Announced the creation of a new Specialty segment – Designed Structures and Solutions • Completed the sale of our non-core resin assets • Realigned our Specialty Coatings business into our GCAI segment Page 6 PP&S 15% Specialty 60% Distribution 25% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010* 2011* 2012* 2015 Target A dj us te d Ea rn in gs P er S ha re Appliance 6% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 4% Consumer 9% Packaging 18% Industrial 10% Misc. 5% HealthCare 9% Transportation 16% Textiles 1% United States 70% Europe 14% Canada 8% Asia 5% Latin America 3% 2012 Revenues: $4.0 Billion* End Markets* 2012 Revenues: $4.0 Billion* EPS Page 7 * Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms & excludes discontinued operations PolyOne At A Glance * Restated to exclude discontinued operations Old PolyOne Transformation *Operating Income excludes corporate charges and special items **Pro Forma results include Spartech and Glasforms acquisitions, Specialty Coatings reclass and excludes resin assets 2% 34% 43% 45% 60% 65 – 75% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2012 2012PF** 2015 % o f O pe ra ti ng In co m e* JV's PP&S Distribution Specialty Specialty OI $5M $46M $87M $114M $150M Target Mix Shift Highlights Specialty Transformation 2015 Target Page 8 2007 Q1 2013 2015 Target 1) Operating Income % Specialty: Global Color, Additives & Inks 4.6% 11.7% 12 – 16% Global Specialty Engineered Materials 1.3% 10.1% 12 – 16% Designed Structures & Solutions -- 4.6% 8 – 10% Performance Products & Solutions 6.1% 8.1% 9 – 12% Distribution 3.0% 6.0% 6 – 7.5% 2) Specialty Platform % of Operating Income 20% 60% 65 – 75% 3) ROIC* (after-tax) 7% 9.2% 15% 4) Adjusted EPS Growth N/A 29% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 9 *Percentage of Specialty Platform revenue from products introduced in last five years 19.5% 50.0% 2006 Q1 2013 $20.3 $41.9 2006 2012 14.3% 27.8% 2006 Q1 2013 Research & Development Spending Specialty Platform Vitality Index Progression* Innovation Drives Earnings Growth ($ millions) Specialty Platform Gross Margin % Page 10 We are Experts in Polymer Science and Formulation Polymer Science Formulation Chemistry Processing Inputs Base Resins Additives Modifiers Colorants Specialized Polymer Materials, Services, and Solutions Expertise Satisfied Consumers PolyOne Customer Innovative Products & Services Marketplace Demands Performance Requirements Value Drivers Page 11 Positioned for Strong Growth 2015 Target Rev: $5B Adj. Average Debt Q1 2012 Q2 2012 Q3 2012 Q4 2012 Q1 2013 Average PolyOne Debt $ 706.4 $ 705.8 $ 705.2 $ 706.9 $ 1055.5 $ 776.0 Average Equity Q1 2012 Q2 2012 Q3 2012 Q4 2012 Q1 2013 Average PolyOne shareholders’ equity $ 611.3 $ 604.3 $ 629.3 $ 629.1 $ 871.8 $ 669.2 Platform sales and operating income (OI) 2012Y* 2012PF** Q1 2013 Global Specialty Engineered Materials Sales $ 543.6 $ 773.0 $ 159.8 Global Color, Additives and Inks Sales 703.5 828.5 205.3 Designed Structures & Solutions -- 850.6 41.5 Specialty Platform Sales $ 1,247.1 2,452.1 406.6 Performance Products and Solutions Sales 837.0 696.1 159.7 PolyOne Distribution Sales 1,030.3 1,030.3 268.0 Corporate and Eliminations (121.8) (121.6) (33.2) Total Sales $ 2,992.6 $ 4,056.9 $ 801.1 Global Specialty Engineered Materials OI $ 47.0 $ 47.7 $ 16.2 Global Color, Additives and Inks OI 66.8 81.6 24.1 Designed Structures & Solutions -- 20.9 1.9 Specialty Platform OI $ 113.8 $ 150.2 $ 42.2 Performance Products and Solutions OI 74.9 37.4 13.0 PolyOne Distribution OI 66.0 66.0 16.2 Corporate and eliminations (33.7) (40.0) (14.3) Special items in OI (53.9) (53.9) (16.6) Operating income - GAAP $ 167.1 $ 159.7 $ 40.5 Special items in OI 53.9 53.9 16.6 Operating income adjusted $ 221.0 $ 213.6 $ 57.1 Global Specialty Engineered Materials - OI % of sales 8.6% 6.1% 10.1% Global Color, Additives and Inks - OI % of sales 9.5% 9.8% 11.7% Designed Structures & Solutions -- 2.5% 4.6% Specialty platform OI % of sales 9.1% 6.1% 10.4% PP&S operating OI % of sales 9.0% 5.4% 8.1% Distribution OI % of sales 6.4% 6.4% 6.0% PolyOne OI adjusted, % of sales 7.4% 5.3% 7.1% PolyOne Investor Presentation�Credit Suisse Boston Basic Materials Conference ��2013年6月26日� Forward – Looking Statements Use of Non GAAP Measures Strategy and Execution Drive Results – Since 2006: Four Pillar Strategy 2013 Portfolio Transformation Highlights PolyOne�At A Glance Mix Shift Highlights Specialty Transformation Proof of Performance & 2015 Goals Innovation Drives Earnings Growth We are Experts in Polymer Science and Formulation Positioned for Strong Growth First Quarter Financial Highlights Debt Maturities & Liquidity Summary – 3/31/13 Use of Cash Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2020-10/2020-gravi-tech-processing-guide.pdf
Gravi-Tech™ Density Modified Formulations PROCESSING GUIDE 2 Gravi-Tech GRAVI-TECH™ Density Modified Formulations Gravi-Tech™ polymer-metal composites are high-density materials developed as thermoplastic-based alternatives to lead and other traditional metals. These materials have been formulated using select metallic fillers and engineered thermoplastic resins to have densities similar to actual metals, while also providing the design flexibility and processing ease of conventional thermoplastics.
https://www.avient.com/sites/default/files/resources/Novel_Thermoplastic_Elastomers_with_Universal_Bonding_Characteristics.pdf
Each formulation was designed to selectively bond to a substrate based on the functionality of the substrate material. As the formulation was altered, bondability of TPE-2 to a substrate varied. CONCLUSION Two classes of TPE formulations have been developed and studied for rigid thermoplastics overmolding applications.
https://www.avient.com/sites/default/files/2021-01/wire-and-cable-one-pager.pdf
APPLICATIONS: Power cables, Ethernet category cables, industrial cables, solar installation cables, coaxial cables, fiber optics, hybrid cables SYNCURE™ Cross-Linked Polyethylene for Power Cable Insulation • Resistant to heat, oil, creep and abrasion • Fast extrusion speeds • UL 44 & UL 4703 flame performance • UL/CSA bulletins MAXXAM™ FR W&C Flame Retardant Polypropylene for Category Cable Insulation and Cross-Webs • Alternative to FEP • Low dielectric • Thin wall extrusion capabilities • UL 94 & plenum yellow card, V-2, V-0 & 5VA fire performance ratings FIRECON™ Flame Retardant Chlorinated Polyethylene for Industrial Cable Jackets • Resistance to harsh environments • Low temperature properties • UV resistance • UL 44 flame performance ECCOH™ LSFOH Low Smoke and Fume, Non-Halogen for Insulation and Jackets • Low smoke and toxicity • Improved fire safety • Resistance to chemicals • UL44 and CPR flame performance ADDITIONAL SOLUTIONS MAXXAM™ SY Foamed Polypropylene for Coaxial Cable Insulation SYNPRENE™ Flame Retardant Thermoplastic Elastomers POLYMIX™ Customer Proprietary Formulations For more information, please visit avient.com or call +1.844.4AVIENT (+1.844.428.4368).
https://www.avient.com/sites/default/files/2020-08/carbonerro-paddle-case-study.pdf
Using this process together with an advanced composite polymer formulation from Avient would offer a better stiffness-to-weight ratio than that of aluminum and mandrel-made fiberglass.
https://www.avient.com/sites/default/files/2022-10/Hoyt VITALPOINT Grip Case Study.pdf
To correct this, Hoyt needed a new material formulation that could be used with their patented shape, would weather well, and provide an ergonomic feel with the proper durometer.
https://www.avient.com/sites/default/files/2022-09/Cesa Laser Marking Additives for Transportation Industry Bulletin.pdf
Avient has experience formulating Cesa Laser Marking Additives that can work with a wide variety of polymers and processes, including injection molding, blow molding and extrusion.
https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Bio-based Polymer Solutions Application Bulletin.pdf
KEY CHARACTERISTICS • Available for polyethylene, polypropylene, ABS, polycarbonate and styrenics • Bio-content of resin carrier varies from 70% to 100% depending on polymer—calculated to ASTM D6866 standard • Manufactured at four ISO 13485 certified sites, providing global consistency and security of supply • Documented change control beyond CAS number, reducing risk of change • Drop-in solutions that can be processed like fossil-based grades on common injection molding and extrusion machines • Can be provided as ready-to-use pre-colored or additive formulation REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 - USP and (incl. class VI) - European Pharmacopeia, monograph 3.1.3/ 3.1.5 (polyolefin packaging materials) - USP (polyethylene) - Elemental impurities as per ICH Q3D • Registered Drug Master File (Type III) and/or Device Master File • Food contact according to US FDA and APPLICATION BULLETIN Sustainability Spotlight Bio-polymers Healthcare use limitations apply—see below.
https://www.avient.com/sites/default/files/2023-08/EVSE Industry Bulletin.pdf
Custom formulations can also be developed using Smartbatch™ Combination Colorants & Additives, combining colors and effects with functionality to meet specific requirements.